Karen Buchkovich
- Oncology top 1%
- Molecular Biology top 5%
- Genetics top 2%
- Ophthalmology top 0.5%
- Immunology top 10%
- Co-authors
- Ed HarlowLinda DuffyPeter WhyteJonathan M. HorowitzRobert A. WeinbergStephen FriendCarol W. GreiderNicholas J. Dyson
- Topics
- Virus-based gene therapy research (7 papers)Cancer-related Molecular Pathways (7 papers)Ocular Oncology and Treatments (6 papers)
- Cited by
- OphthalmologyOncologyGenetics
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Karen Buchkovich
14 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 2.2k
- Molecular Biology 1.9k
- Genetics 1.2k
- Ophthalmology 762
- Immunology 389
Countries citing papers authored by Karen Buchkovich
This map shows the geographic impact of Karen Buchkovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Buchkovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Buchkovich more than expected).
Fields of papers citing papers by Karen Buchkovich
This network shows the impact of papers produced by Karen Buchkovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Buchkovich. The network helps show where Karen Buchkovich may publish in the future.
Co-authorship network of co-authors of Karen Buchkovich
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Buchkovich. A scholar is included among the top collaborators of Karen Buchkovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Buchkovich. Karen Buchkovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice. | 76 |
| 3 | 183 | |
| 4 | 3 | |
| 5 | 48 | |
| 6 | 22 | |
| 7 | 97 | |
| 8 | 306 | |
| 9 | 268 | |
| 10 | The retinoblastoma protein is phosphorylated during specific phases of the cell cyclebreakdown → | 892 |
| 11 | Cellular proteins that are targetted by DNA tumor viruses for transformation. | 24 |
| 12 | 358 | |
| 13 | Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene productbreakdown → | 1219 |
| 14 | 6 |
About Karen Buchkovich
Karen Buchkovich is a scholar working on Ophthalmology, Aging and Oncology, having authored 14 papers that have together received 3.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), Cancer-related Molecular Pathways (7 papers) and Ocular Oncology and Treatments (6 papers). The work is most often cited by research in Ophthalmology (762 citations), Oncology (2.2k citations) and Genetics (1.2k citations). Karen Buchkovich has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Ed Harlow, Linda Duffy, Peter Whyte, Jonathan M. Horowitz, Robert A. Weinberg, Stephen Friend, Carol W. Greider, Nicholas J. Dyson, Carl W. Anderson and D R Marshak. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.